US lawmakers warn of dangerous dependence on China for key medicine ingredients. Experts say this poses risks to public health and national security. https://english.mathrubhumi.com/news/world/us-pharmaceutical-dependence-on-china-security-risk-ab2igg1b?utm_source=dlvr.it&utm_medium=mastodon #USPharmaceuticals #ChinaMedicineSupply #GenericDrugs
#RxInspector: ProPublica’s New Tool Provides #Drug Info the #FDA Won’t
Even though #genericdrugs make up 90% of #prescriptions dispensed in the #US, the FDA only provides piecemeal information about them. It’s scattered across different websites with no easy way to link #drugs to their manufacturers, factory locations and regulatory track records. Over many months, journalists connected that data.
https://www.propublica.org/article/rx-inspector-prescription-drug-lookup
Rx Inspector: ProPublica’s New Tool Provides Drug Info the FDA Won’t

We’ve launched a first-of-its-kind app to help you find out where your generic drugs come from and see the track records of the factories that made them.

ProPublica

ProPublica: ProPublica Publishes Unreleased Data on the Origins of Generic Prescription Drugs. “The data, which ProPublica created by linking several FDA datasets, has never been made available by the agency before. It will allow anyone to connect prescriptions to the facilities they were manufactured in by linking National Drug Code numbers to FDA Establishment Identifiers of drug […]

https://rbfirehose.com/2026/01/26/propublica-propublica-publishes-unreleased-data-on-the-origins-of-generic-prescription-drugs/
ProPublica: ProPublica Publishes Unreleased Data on the Origins of Generic Prescription Drugs

ProPublica: ProPublica Publishes Unreleased Data on the Origins of Generic Prescription Drugs. “The data, which ProPublica created by linking several FDA datasets, has never been made availab…

ResearchBuzz: Firehose

The FDA’s Lax Generic Drug Rules Can Put Patients’ Lives at Risk

Generic drugs are supposed to be equivalent to brand-name medications — but the FDA doesn’t always ensure that.

https://murica.website/2026/01/the-fdas-lax-generic-drug-rules-can-put-patients-lives-at-risk/

The FDA’s Lax Generic Drug Rules Can Put Patients’ Lives at Risk – The USA Potato

https://www.propublica.org/article/fda-generic-drug-testing

https://www.404media.co/flock-exposed-its-ai-powered-cameras-to-the-internet-we-tracked-ourselves/?ref=daily-stories-newsletter

So many things we could be doing and need to be doing. But the President is afraid of wind, looking to annex Greenland and start a war with Venezuela, and make America white again.

#flock #genericdrugs #fda @ProPublica @404mediaco

The FDA Often Doesn’t Test Generic Drugs for Quality Concerns, So ProPublica Did

Billions of prescriptions for generic drugs are filled in the U.S. annually. The FDA tests only a few dozen of them every year, its own records show, and it has largely dismissed warnings about contaminants, irregularities and other issues.

ProPublica

U.S. Senators Address Risks of Foreign Drug Supply Dependence

At a Senate Special Committee on Aging hearing titled 'Bad Medicine: Closing Loopholes that Kill American Patients,' U.S. lawmakers highlighted the national security and public health risks posed by the country's reliance on foreign drug supplies, particularly from China and India. The U.S. imports ... [More info]

💊 Affordable Cancer Care is Possible!
Did you know generic oncology drugs can make life-saving treatments more accessible and affordable? Learn how these options are closing the gap in cancer care. 🌟

🔗 Read more: https://www.mrmed.in/health-library/health-care/affordable-cancer-care-generic-oncology-drugs-india

#AffordableCancerCare #GenericDrugs #OncologyCare #CancerTreatment #HealthForAll #PatientFirst #MrMedCare

Affordable Cancer Care in India: How Generic Oncology Drugs Close the Gap?

Discover how generic oncology drugs in India make cancer treatment affordable. Learn the cost difference, benefits, and challenges of using generic cancer medicines.

FDA Knew Drugmaker Had Poor Record. It Waited Four Years to Inspect One Factory.

A Glenmark Pharmaceuticals factory in central India had been producing a generic drug linked to U.S. deaths.

https://murica.website/2025/07/fda-knew-drugmaker-had-poor-record-it-waited-four-years-to-inspect-one-factory/

FDA Knew Drugmaker Had Poor Record. It Waited Four Years to Inspect One Factory. – The USA Potato